Method of inhibiting transformed cells

Details Method of inhibiting transformed cells Method of inhibiting transformed cells

1994-02-18

1996-08-13

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3144

Patent

active

055456391

ABSTRACT:
The present invention relates to a method for the inhibition of transformed cells, comprising the application of an effective amount of at least one of the group consisting of 2,9-bis(halomethyl)-1,10-phenanthroline and structural congeners thereof.

REFERENCES:
patent: 2617753 (1952-11-01), Gysin et al.
Albert, "Metal-binding substances," in Selective Toxicity, 7th ed., Chapter 11, 430-489 (1981).
Berger et al., "Othro-Phenanthroline Inhibition of DNA Synthesis in Mammalian Cells," Exp. Cell Res., 96, 145-155(1975).
Blank, "In vitro fungistatic action of phenanthrolines against pathogenic fungi," Nature, 168, 516-517 (1951).
Bridgland et al., "N-oxide complexes of vanadium(IV) chloride, " J. Inorg. Nucl. Chem., 31, 43-48 (1969).
Chassapis et al., "Chelates of the Rare Earth Notrates with 1,10-Phenanthroline-N,N'-Dioxide," Inorganica Chimica Acta, 27, 67-68 (1978).
Falchuk et al., "1,10-Phenanthroline Inhibition of Lymphoblast Cell Cycle," Cancer Res., 37, 2050-2056 (1977).
Mathes et al., "(Halogenomethyl)pyridines and (Halogenomethyl)quinolines,"Angew. Chem Internat. Ed., 2, 144-149 (1963).
Mohindru et al., "2,9-Dimethyl-1,10-Phenanthroline (neocuproine): A Potent, Copper-Dependent Cytotoxin with Anti-Tumor Activity," Biochem. Pharmacol., 32, 3627-3632 (1983).
Newkome et al., "Mono-.alpha.-functionalization of 2,9-Dimethyl-1,10-Phenanthroline," J. Org. Chem., 54, 1766-1769 (1989).
Newkome et al., ".alpha.-Methyl Functionalization of Electron-Poor Heterocycles: 2,9-Bis(chloromethyl)-1,10-phenanthroline. Synthesis of a [3,3]Cyclophane Containing the 1,10-Phenanthroline Moiety," J. Org. Chem., 48, 5112-5114 (1983).
Shulman et al., "Action of 1, 10-Phenanthroline Transition Metal Chelates of P388 Mouse Lymphocytic Leukaemic Cells," Chem.-Biol. Interactions, 16, 89-99 (1977).
Shulman et al., "Virostatic Activity of 1,10-Phenanthroline Transition Metal Chelates: A Structure-Activity Analysis," Chem. Biol. Interactions, 6, 407-413 (1973).
Shulman et al., "The Lethal Action of 1,10-Phenanthroline Transition Metal Chelates and Related Compounds on Dermatophytes and Candida albicans," Arzneim.-Forsch. (Drug Res.), 22,, 154-158 (1972).
Shulman et al., "Metal Chelates in Biological Systems," in Chelating Agents and Metal Agents, Dwyer et al., eds., Chapter 9, 383-439 (Academic Press, New York, NY, 1964).
Sliwa, "1,10-Phanenthroline and its Complexes," Heterocycles, 12, 1207-1237 (1979).
Toissel, "Table of Intravenous Infusion Solutions," ASHP Handbook on Injectable Drugs, 4th ed., 622-630 (1986).
Butler et al., "Bactericidal action of selected phenthroline chelates and related compounds," Aust. J. Exp. Biol. Med. Sci., 47, 541-552 (1969).

Affiliated with

Also associated with

Rating

Method of inhibiting transformed cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting transformed cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting transformed cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1048066